Postoperative Risk of IDH-Mutant Glioma–Associated Seizures and Their Potential Management With IDH Mutant Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Clinical Investigation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Postoperative risk of IDH mutant glioma-associated seizures and their potential management with IDH mutant inhibitors
J. Clin. Invest. 2023 Apr 27;[EPub Ahead of Print], M Drumm, W Wang, TK Sears, K Bell-Burdett, R Javier, KY Cotton, BT Webb, KT Byrne, D Unruh, V Thirunavu, J Walshon, A Steffens, K McCortney, RV Lukas, JJ Phillips, E Mohamed, JD Finan, L Santana-Santos, AB Heimberger, CK Franz, JE Kurz, JW Templer, GT Swanson, C HorbinskiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.